by
Prof.Gert Auer(Karolinska Institute), Prof.Hans Wiksell(Karolinska Institute)
→
Europe/Stockholm
FA32
FA32
Description
Breast cancer is the most frequent carcinoma in women, accounting for 22 - 26 % of all female cancers. In Sweden approx. 7,200 new cases are diagnosed per year. Essential for curing breast cancer is early detection. Approx. ten patients must be diagnosed to detect one single cancer, therefore the diagnose method should be lenient as is fine needle biopsy based on cytology.
Sensitive methods will be developed in a new international EU-financed teamwork named "FLUODIAMON" (coordinator Jerker Widengren).
We have performed a scientific critical study on Fine Needle Aspiration (FNA) which have generated some new and improved components, we have developed a (controversial) technique to eliminate or reduce seeding of cancer cells during biopsy, and we have developed a new method to cure smaller well selected breast cancer tumors by precision controlled heat, named "Preferential Radio Frequency Ablation" which now is used at St Göran’s hospital in Stockholm. Our vision is to combine all three techniques at the very same session.
During this seminar Gert Auer and Hans Wiksell will discuss some of the physics involved in the diagnostic tissue sampling, in the anti-seeding procedure, and in the PRFA-treatment regime.
Welcome!
